10 reports

  • Prominent Sponsors
  • Clinical Trials by Sponsor Type

CLINICAL TRIAL OVERVIEW OF AMAG PHARMACEUTICALS, INC.

  • Clinical Trial
  • Ear Disease
  • Pharmaceutical
  • Therapy
  • Auris Medical Holding AG
  • Auris Medical Holding AG, Pharmaceuticals & Healthcare, Deals By Year, 2011 to YTD 2017
  • Auris Medical Holding AG, Pharmaceuticals & Healthcare, Deals Summary, 2012 to YTD 2018

Summary Auris Medical Holding AG (Auris Medical) is a clinical-stage biopharmaceutical company that develops therapeutics to address unmet medical needs in the area of otolaryngology.The company’s pipeline encompasses investigational candidates targeted at the treatment of acute inner ear tinnitus, post-acute inner ear...

  • Pharmaceutical
  • United States
  • Company
  • Corporate Finance
  • Auris Medical Holding AG
  • SOUND PHARMACEUTICALS INC
  • AUDIOCURE PHARMA GMBH

Tinnitus - Pipeline Review, H1 2018 Summary Global Markets Direct’s latest Pharmaceutical and Healthcare disease pipeline guide Tinnitus - Pipeline Review, H1 2018, provides an overview of the Tinnitus (Ear Nose Throat Disorders) pipeline landscape. Tinnitus is a condition characterized by...

  • Pharmaceutical
  • United States
  • World
  • Product Initiative
  • Auris Medical Holding AG
  • AURIS MEDICAL HOLDING AG, PHARMACEUTICALS & HEALTHCARE, DEALS BY TYPE, 2011 TO YTD 2017
  • Auris Medical Holding AG, Pharmaceuticals & Healthcare, Deals By Year, 2011 to YTD 2017

Auris Medical Holding AG (EARS) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses and the potential opportunities and...

  • Pharmaceutical
  • United States
  • World
  • Company Financials
  • Auris Medical Holding AG
  • Market Cap. Comparison by Companies (2016)

This is one of the target indication for many pharmaceutical companies.

  • Pharmaceutical
  • World
  • Company
  • Forecast
  • Auris Medical Holding AG
  • AUDIOCURE PHARMA GMBH
  • SOUND PHARMACEUTICALS INC

Tinnitus - Pipeline Review, H2 2017 Summary Global Markets Direct’s latest Pharmaceutical and Healthcare disease pipeline guide Tinnitus - Pipeline Review, H2 2017, provides an overview of the Tinnitus (Ear Nose Throat Disorders) pipeline landscape. Tinnitus is a condition characterized by ringing, swishing,...

  • Ear Disease
  • Pharmaceutical
  • United States
  • Product Initiative
  • Auris Medical Holding AG
  • INNER EAR DRUG DEVELOPERS: NUMBER OF DRUGS UNDER DEVELOPMENT
  • APPENDIX 2: LIST OF COMPANIES AND

INTRODUCTION A significant proportion of the world’s population is suffering from otologic diseases. Absence of any disease modifying drugs is a big unmet need in the market. The current treatment of inner ear diseases is primarily based on counselling, electric and magnetic nerve stimulations. At the same time, there is a growing...

  • Hospital
  • Pharmaceutical
  • United States
  • Demand
  • Auris Medical Holding AG

KG ## ## ## ## ## ## O-Ray Pharma, Inc. ## ## ## ## ## ## Orbis Biosciences Inc ## ## ## ## ## ## Otologic Pharmaceutics, Inc. ## ## ## ## ## ## Pragma Therapeutics ## ## ## ## ## ## Xigen SA ## ## ## ## ## ##

  • Pharmaceutical
  • United States
  • World
  • Product Initiative
  • Auris Medical Holding AG
  • Tinnitus Therapeutics Clinical Trials, Global, Key Sponsors, 2016* Sponsor Name
  • Tinnitus Therapeutics Clinical Trials, Global, Top Companies by Phase, 2016*

GDCT ID is the unique ID of GlobalData' s Pharma eTrack clinical trial database ##.

  • Ear Disease
  • Pharmaceutical
  • World
  • Product Initiative
  • Auris Medical Holding AG
  • Auris Medical Holding AG Overview
  • Auris Medical Holding AG, Key Facts

The company develops pharmaceutical therapies to protect hearing and to silence tinnitus.

  • Pharmaceutical
  • World
  • Company Operations
  • Product Initiative
  • Auris Medical Holding AG